Eli Lilly warns against counterfeit, compounded Mounjaro and Zepbound due to shortages and black market sales.
Eli Lilly has warned of the dangers of counterfeit and compounded versions of its diabetes and weight loss medications, Mounjaro and Zepbound, due to increased demand leading to shortages and black market sales. The pharmaceutical company has filed lawsuits against wellness centers and medical spas advertising these drugs and has warned consumers against using products labeled "research purposes only" or "not for human consumption." Eli Lilly has also expressed concerns about compounding pharmacies producing substandard products during the ongoing drug shortage.
June 20, 2024
8 Articles